Back

Why to avoid dual primary endpoints in cardiovascular trials

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Epidemiological trends in cardiovascular medicine: a data-driven approach Biostatistics ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Nele Henrike Thomas

Institute for Biostatistics, Hannover (Germany)

4 More presentations in this session

Presentation thumbnail
What is the evidence behind new I-A and III-A recommendations in European Society of Cardiology guidelines?
Doctor R. Bansal (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Major cardiovascular events after admission to intensive care units: A Danish nationwide cohort study
Doctor K. Feldballe Bernholm (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Ketone body ratio as a predictor of heart failure incidence: findings from a 15-year longitudinal cohort study
Doctor K. Saadeh (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Metabolic signature of prevalent cardiovascular diseases
Mr M. Dziedzic (Cracow, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiological trends in cardiovascular medicine: a data-driven approach

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Analysis of recurrent heart failure hospitalisations: why mortality assessment should be the gatekeeper
thumbnail
Congress Session
Cardiology Toolbox - Clinical trial design
thumbnail
Congress Presentation
Event rates in major phase 3 heart failure trials over the past 20 years

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources